Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes
Authors:
- Hartmut GöbelHartmut Göbel
- Axel HeinzeAHAxel Heinze
- Katja Heinze-KuhnKHKatja Heinze-Kuhn
- Kristina AustermannKAKristina Austermann
- 1 April 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Pain
- Vol. 91 (3) , 195-199
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open‐label studyOtolaryngology–Head and Neck Surgery, 2000
- Session 16: ProphylaxisCephalalgia, 2000
- Session 15: PharmacologyCephalalgia, 2000
- Treatment of Chronic Cervical‐Associated Headache With Botulinum Toxin A: A Pilot StudyHeadache: The Journal of Head and Face Pain, 2000
- The use of botulinum toxin for the treatment of temporomandibular disorders: Preliminary findingsJournal of Oral and Maxillofacial Surgery, 1999
- The mechanism of action of Botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected siteJournal of the Neurological Sciences, 1997
- Botulinum toxin in the treatment of myofascial pain syndromePain, 1994
- Treatment of Myofascial Pain with Botulinum A ToxinAnesthesiology, 1994
- Botulinum a Toxin Effects on Rat Jaw Muscle SpindlesActa Oto-Laryngologica, 1993
- Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasmMovement Disorders, 1987